A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

Lucy Vivash, Charles B. Malpas, Leonid Churilov, Mark Walterfang, Amy Brodtmann, Olivier Piguet, Rebekah M. Ahmed, Ashley I. Bush, Christopher M. Hovens, T. Kalincik, David Darby, Dennis Velakoulis, Terence J. O'Brien

Research output: Contribution to journalArticleOtherpeer-review

10 Citations (Scopus)

Search results